A post hoc analysis of an RCT in patients with SLE treated with IL-2 reported a negative correlation between Treg and disease activity as assessed by the erythrocyte sedimentation rate (ESR) (r = −0.382, p<0.01) (12). The gene discussed is IL2; the disease is systemic lupus erythematosus.